June 5, 2018, Vol 319, No. 21, Pages 2149-2244
Value-Based Pricing for DrugsTheme and Variations
Anna Kaltenboeck, MA; Peter B. Bach, MD
JAMA. 2018;319(21):2165-2166. doi:10.1001/jama.2018.4871
In this Viewpoint, Peter Bach and colleagues distinguish 5 pricing reform proposals implied by the concept of value-based drug pricing and discuss the potential of each to ensure value in response to unsustainable drug price increases.